OLIPASS Corporation (KOSDAQ:244460)
South Korea · Delayed Price · Currency is KRW 1,651.00
-267.00 (-13.92%)
At close: Apr 7, 2025
OLIPASS Market Cap
OLIPASS has a market cap or net worth of 8.4 billion as of February 13, 2026. Its market cap has decreased by -57.20% in one year.
Market Cap
8.40B
Enterprise Value
7.93B
Revenue
5.25B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,651.00
Market Cap Chart
Since September 20, 2019, OLIPASS's market cap has decreased from 344.12B to 8.40B, a decrease of -97.56%. That is a compound annual growth rate of -48.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2025 | 8.40B | -63.10% |
| Dec 30, 2024 | 22.77B | -14.18% |
| Dec 28, 2023 | 26.53B | -85.86% |
| Dec 29, 2022 | 187.57B | -21.32% |
| Dec 30, 2021 | 238.38B | -46.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SCM Lifescience | 37.31B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Epibiotech | 34.42B |
| ADBiotech | 32.47B |
| Moogene Medi | 19.98B |
| Plumbline Life Sciences | 18.93B |
| Femtobiomed | 12.34B |